First Eagle Investment Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-60,000
Closed -$347K 363
2016
Q2
$347K Sell
60,000
-319,727
-84% -$2.04M ﹤0.01% 278
2016
Q1
$2.3M Buy
379,727
+179,727
+90% +$1.08M 0.01% 201
2015
Q4
$1.83M Hold
200,000
﹤0.01% 204
2015
Q3
$1.13M Buy
+200,000
New +$1.65M ﹤0.01% 218
2015
Q2
Sell
-559,780
Closed -$7.22M 324
2015
Q1
$8.78M Hold
559,780
0.02% 166
2014
Q4
$8.51M Buy
559,780
+23,400
+4% +$284K 0.02% 166
2014
Q3
$5.79M Hold
536,380
0.01% 183
2014
Q2
$8.19M Buy
536,380
+136,380
+34% +$1.96M 0.02% 178
2014
Q1
$7.23M Sell
400,000
-447,550
-53% -$8.63M 0.02% 154
2013
Q4
$11.8M Hold
847,550
0.03% 140
2013
Q3
$8.88M Buy
847,550
+423,200
+100% +$4.2M 0.03% 160
2013
Q2
$3.31M Buy
+424,350
New +$3.7M 0.01% 208

Other funds holding SGMO

First Eagle Investment Management's SGMO Position: Q3 2016 in Review

First Eagle Investment Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2016, closing a stake of 60,000 shares — an estimated $347K sold.

First Eagle Investment Management first reported a position in SGMO in Q2 2013 and held it in 12 quarters. The position peaked at $11.8M in Q4 2013. 124 funds tracked by Wall St. Rank hold SGMO as of Q3 2016.

  • First Eagle Investment Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2016 after selling out during the quarter.
  • First Eagle Investment Management sold 60,000 SANGAMO THERAPEUTICS INC shares in Q3 2016, an estimated $347K.
  • First Eagle Investment Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 12 quarters.
  • First Eagle Investment Management's SANGAMO THERAPEUTICS INC position peaked at $11.8M in Q4 2013.
  • 124 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2016.

Based on First Eagle Investment Management's 13F filing for Q3 2016, filed 7 Nov 2016.